Outlook Therapeutics, Inc. - Common Stock, $0.01 par value per share (OTLK)

Historical Holders from Q1 2023 to Q3 2025

Symbol
OTLK on Nasdaq
Type / Class
Equity / Common Stock, $0.01 par value per share
Shares outstanding
46,752,465
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
4,043,704
Holdings value
$4,285,787
% of all portfolios
0%
Number of holders
52
Number of buys
20
Number of sells
40
Average buys %
+0%
Average sells %
-0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Outlook Therapeutics, Inc. - Common Stock, $0.01 par value per share (OTLK) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
GMS Ventures & Investments 50% +21% $45,303,849 +$20,057,142 29,040,929 +79% GMS VENTURES & INVESTMENTS 27 May 2025
SPHERA FUNDS MANAGEMENT LTD. 7.5% +46% $3,548,568 +$1,182,856 2,571,426 +50% Sphera Funds Management Ltd. 10 Apr 2025
Empery Asset Management, LP 5% -32% $2,472,925 -$914,455 2,332,948 -27% Empery Asset Management, LP 30 Sep 2025
GREAT POINT PARTNERS LLC 5% -23% $2,419,800 2,220,000 0% Great Point Partners, LLC 30 Jun 2025
TANG CAPITAL PARTNERS LP 6.4% $2,321,853 1,682,502 TANG CAPITAL MANAGEMENT, LLC 31 Dec 2024
TANG CAPITAL MANAGEMENT LLC 3.4% -37% $1,635,000 -$436,000 1,500,000 -21% TANG CAPITAL MANAGEMENT, LLC 30 Jun 2025
As of 30 Sep 2025 Outlook Therapeutics, Inc. - Common Stock, $0.01 par value per share (OTLK) has 52 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 4,043,704 shares of 46,752,465 outstanding shares and own 8.6% of the company stock as of 30 Sep 2025.

Top 25 institutional shareholders of Outlook Therapeutics, Inc. - Common Stock, $0.01 par value per share (OTLK) own 8.5% of the company based on 13F filings as of 30 Sep 2025

Filer Ownership Holdings Value Nb Shares Share Change %
VANGUARD GROUP INC 2.9% $1,423,185 1,342,627 +7.3%
Schonfeld Strategic Advisors LLC 1.5% $758,078 715,170 -48%
BlackRock, Inc. 0.79% $391,918 369,734 +8.8%
GEODE CAPITAL MANAGEMENT, LLC 0.66% $324,747 306,295 +15%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 0.45% $224,106 211,421 +80%
MILLENNIUM MANAGEMENT LLC 0.42% $206,258 194,583 -43%
COMMONWEALTH EQUITY SERVICES, LLC 0.24% $120,000 113,151 +302%
BANK OF AMERICA CORP /DE/ 0.19% $95,904 90,475 +1058%
SIMPLEX TRADING, LLC 0.19% $94,000 89,241
STATE STREET CORP 0.16% $79,820 75,302 -12%
SCOTIA CAPITAL INC. 0.16% $78,428 73,989 0%
LVW Advisors, LLC 0.1% $51,130 48,235 +130%
UBS Group AG 0.1% $51,001 48,114 -13%
GOLDMAN SACHS GROUP INC 0.09% $45,548 42,970 -53%
TWO SIGMA SECURITIES, LLC 0.08% $37,804 35,664
LPL Financial LLC 0.06% $30,129 28,424 +88%
Christensen, King & Associates Investment Services, Inc. 0.06% $28,840 27,208 +12%
NORTHERN TRUST CORP 0.06% $27,633 26,069 -33%
JANE STREET GROUP, LLC 0.06% $27,375 25,825 -64%
Flower City Capital 0.04% $21,200 20,000
GROUP ONE TRADING LLC 0.04% $17,843 16,833 -38%
CITIGROUP INC 0.03% $16,937 15,978 -7.1%
Russell Investments Group, Ltd. 0.03% $16,428 15,498 -37%
Vanguard Personalized Indexing Management, LLC 0.03% $14,726 13,892 +5%
Qube Research & Technologies Ltd 0.03% $14,148 13,347 -52%

Institutional Holders of Outlook Therapeutics, Inc. - Common Stock, $0.01 par value per share (OTLK) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price Investors
2025 Q3 4,043,704 $4,285,787 -$2,292,842 $1.06 52
2025 Q2 5,938,598 $9,501,555 -$1,298,119 $1.60 63
2025 Q1 7,084,422 $8,644,636 +$2,800,473 $1.22 61
2024 Q4 4,545,482 $8,586,535 -$17,552,083 $1.89 60
2024 Q3 7,927,898 $42,334,510 -$3,223,880 $5.34 68
2024 Q2 8,042,692 $59,353,776 +$2,234,338 $7.38 63
2024 Q1 7,236,418 $86,189,472 +$85,985,156 $11.94 53
2023 Q3 34,194 $7,557 $0 $0.2210 1
2023 Q2 34,194 $59,498 $0 $1.74 1
2023 Q1 34,194 $37,271 +$37,271 $1.09 1